OUR PRODUCTS

MOBILE APPS

GENERAL INFO

URGN

Stock ticker: NASDAQ

PRICE

CHANGE

CAPITALIZATION

UroGen Pharma (URGN) Earnings Date & Reports

UroGen Pharma Ltd is a clinical-stage biotechnology firm specializing in solutions for urothelial and specialty cancers... Show more

Industry: #Biotechnology

Get AI intraday signals

A.I. Advisor

published Earnings

URGN is expected to report earnings to fall 39.33% to -63 cents per share on November 17

UroGen Pharma URGN Stock Earnings Reports

Q3'25

Est.

$-0.64

Q2'25

Missed

by $0.22

Q1'25

Missed

by $0.13

Q4'24

Missed

by $0.03

Q3'24

Beat

by $0.27

The last earnings report on August 07 showed earnings per share of -104 cents, missing the estimate of -82 cents. With 1.29M shares outstanding, the current market capitalization sits at 899.84M.

View a ticker or compare two or three

Compare

URGN

Setup

Buy or SellView

Daily Signalchanged days ago

Gain/Loss if bought

View Trends For URGN
(Try 14 days for Free)

Interact to see
Advertisement

A.I.Advisor

published price charts

These past five trading days, the stock lost 0.00% with an average daily volume of 0 shares traded.The stock tracked a drawdown of 0% for this period. URGN showed earnings on August 07, 2025. You can read more about the earnings report here.

View AI-Driven Trading

A.I. Advisor

published General Information

General Information

a developer of therapies for urological pathologies

Industry Biotechnology

Profile

Fundamentals

Details

Industry

Biotechnology

Address

400 Alexander Park Drive

Phone

+1 646 768-9780

Employees

201

Web

https://www.urogen.com